Transplantation Group
Transplantation Group
批准号:
9485286
负责人:
Michelle Lynn Sever
金额:
$304.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AchievementAllergic DiseaseAreaAsthmaAutoimmune DiseasesBiometryChildClinicalClinical InvestigatorClinical ResearchClinical TrialsCollaborationsCommunicationDataData Coordinating CenterData QualityDevelopmentEnsureEthicsFundingFunding OpportunitiesGenomicsHuman ResourcesHypersensitivityImmune ToleranceImmunologyInterventionIntervention StudiesLeadershipManuscriptsMonitorNational Institute of Allergy and Infectious DiseaseObservational StudyOrgan TransplantationOutcomePreparationProcessProtocols documentationReportingResearchResearch InfrastructureResearch PersonnelResearch SupportResourcesScientistServicesSiteSolidStandardizationStatistical Data InterpretationStructureSystemTraining ActivityTransplant RecipientsTransplantationU-Series Cooperative Agreementscostdata managementdesignexperienceimprovedmemberoperationorganizational structureprogramsprotocol developmentrhosuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT—TRANSPLANTATION GROUP
Through this Funding Opportunity Announcement, the NIAID Division of Allergy, Immunology and
Transplantation (DAIT) intends to consolidate its funding for multiple, independent coordinating centers into a
single, multi-component cooperative agreement in order to reduce costs and increase efficiency and
standardization across research consortia. This new program will fund a single Center to support DAIT
research in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation. In the area
of solid organ transplantation, the Center will support 4 consortia: Clinical Trials in Organ Transplantation
(CTOT), Clinical Trials in Organ Transplantation in Children (CTOT-C), Genomics of Transplantation
Cooperative Research Program (GTCRP), and the organ transplantation component of the Immune Tolerance
Network (ITN). Within the Center, support for these 4 consortia will be organized under 1 group, the
Transplantation Group (TG). The objective of the TG is to provide excellent and efficient study coordination
support services across the transplant research consortia. To accomplish this objective, RhoFED aims to (1)
provide staff experienced in transplantation research conducted by DAIT-supported consortia and to organize
these staff in an administrative structure that manages resources efficiently, be responsive to the needs of the
research consortia and DAIT, and facilitate communication and collaboration; (2) provide experienced
scientists and statisticians who, in collaboration with clinical investigators and senior DAIT officials, will design
and analyze studies across the full scope of research in transplantation; (3) facilitate the development, review,
and revision of initial and successive drafts of protocols and protocol-related documents through dedicated TG
protocol teams; and (4) provide study initiation and study management functions that are required for the
efficient and ethical conduct of studies. Because RhoFED is currently the Statistical and Clinical Coordinating
Center (SACCC) for the CTOT, CTOT-C and GTCRP consortia and is the Statistical Data Coordinating Center
(SDCC) for ITN, Rho is uniquely well-qualified to provide consolidated Center support across these consortia.
By providing staff with experience in supporting transplantation research, an administrative infrastructure
designed to enhance collaboration between DAIT Project Officers and the consortia investigators, and a plan
for agile and effective resource management, we believe that support of these consortia through the newly
formed Center and its TG will directly contribute to the achievement of the DAIT objective to improve clinical
outcomes following solid organ transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)
-
批准号:10745577
-
项目类别:
-
资助金额:$873.96万
-
财政年份:2023
-
负责人:Michelle Lynn Sever
-
依托单位:
海外基金